BZYR — BURZYNSKI RESEARCH INSTITUTE INC
—
OTC ·
Health Care ·
Life Sciences Tools & Services ·
CIK 724445 ·
Last close
$0.00
Market Cap
$262.9K
52W High
$0.05
52W Low
$0.00
ADV30
18,750
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Nov 2025 | 0 | — | -328,862 | -328,862 | 2,265 | 2,165 | 69,608 |
| May 2025 | 0 | — | -331,451 | -331,451 | 1,521 | 821 | 71,237 |
| Feb 2025 | 0 | — | -292,798 | -292,798 | 847 | 847 | 42,484 |
| Nov 2024 | 0 | — | -352,239 | -352,239 | 713 | 613 | 22,039 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-1,809,307
Investing CF
—
Financing CF
$1,810,146
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-130,470,593
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-1,305,350
Pretax Income TTM
$-1,305,350
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Feb 2025 | 0 | -1,386,207 | -1,386,207 | 847 | 42,484 | -41,637 | -388,531 |
| Feb 2024 | 0 | -1,335,431 | -1,335,431 | 2,310 | 27,433 | -25,123 | -523,780 |
| Feb 2023 | 0 | -916,292 | -916,292 | 1,934 | 15,661 | -13,727 | -249,516 |
| Feb 2022 | 0 | -976,656 | -976,656 | 4,661 | 3,455 | 1,206 | -325,098 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| FOXO | FOXO TECHNOLOGIES INC. | $231.8K | $0.14 | — |
| CBIH | Cannabis Bioscience International Holdings, Inc. | $1.16M | $0.00 | — |
| VRAX | Virax Biolabs Group Ltd | $1.91M | $2.39 | — |
| ISPC | iSpecimen Inc. | $3.17M | $1.26 | — |
| BUDZ | WEED, INC. | $4.45M | $0.03 | — |
Recent Insider Activity
No insider activity indexed for this ticker.